Pricing

Iovance Biotherapeutics

364 people · 0 jobs

‌

Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.

Industries

Headquarters

San Carlos, United States

Employees

Links

Org chart

Frederick G. Vogt

Interim CEO, President & General Counsel

Collapse

COO

Friedrich Graf Finckenstein

Chief Medical Officer

Howard B. Johnson

Chief Business Officer

SVP, Head of Digital & Information Technology

EVP, Human Resources

EVP, Quality

SVP, Research

Jessica Reckner

Senior Director Of Marketing

Stefanie Bulilan

Sr. Director Quality Systems And Compliance

Kerry Elizabeth Wilson Esq.

Executive Counsel

Executive Counsel

Chief Commercial Officer (cco)

Sara Pellegrino

Svp, Investor Relations & Corporate Communications

Marcela Batista-Mujica

Executive Assistant To President & CEO

Senior Patent Counsel

Associate General Counsel

Matthew Rosinack

Senior Vice President Finance

Michele Fernandes

SVP Portfolio Management

Sr. Manager, Global Consolidation

Board & advisors

Chairman

Director

Director

Director

Athena Countouriotis

Director

Director

Teams

Leadership Team

23 people · 0 jobs

Clinical Operations and Research

10 people · 0 jobs

Quality Assurance and Compliance

13 people · 0 jobs

Information Technology and Data Management

11 people · 0 jobs

Finance and Accounting

8 people · 0 jobs

Human Resources and Talent Acquisition

6 people · 0 jobs

Offices

HQ
34 people · 0 jobs
MA
+30

Similar companies

Editas Medicine

5 followers

Arcus Biosciences

3 followers

Gilead Sciences

161 followers

Regeneron

133 followers

Illumina

79 followers

Agilent Technologies

84 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

45 followers

GRAIL

29 followers

Cytiva

16 followers

CRISPR Therapeutics

12 followers

Explore companies